Recipharm, a Sweden-based contract development and manufacturing organisation, has installed a new blow-fill-seal (BFS) machine at its facility in Kaysersberg, France.
The company has invested €18 million (£16 million) into the new BFS high-speed filling and the eighth packaging line.
Go deeper with GlobalData
The move has added another 2,400m² to the facility, thereby providing space for installation of three more machines.
The new machine is set to increase the manufacturing capacity of the Kaysersberg facility by 200 million unidoses each year. This allows the company to annually produce more than 1.2 billion unidoses.
Recipharm Kaysersberg site general manager Yves Buelens said: “Recipharm has only owned the facility for two years and during that time have taken some very fast and positive decisions to invest in Kaysersberg.
“We have worked hard to develop a flexible service that can cater for even the most complex of projects. Adding the line to our facility will allow us to take on new customer projects more quickly, as well as continue to meet our current customers’ requirements.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData“The additional space we’ve added also means we are well positioned for further growth in line with future customer demand.”
Recipharm says that the new machine will help meet the growing demand for single-dose and sterile manufacturing services, which include aseptic processing for eye and ear care products, particularly from markets such as the US, Turkey, Australia and Canada.
